Can charcoal hemoperfusion treatment be an option for pediatric MIS-C patients? A single-center experience in a tertiary pediatric intensive care unit.
Fatih VarolEbru G SahinMehmet CengizAziz KilicZeynep Meva AltasSirin GuvenHalit CamPublished in: Journal of clinical apheresis (2022)
In our opinion, this study is the first report regarding the use of charcoal hemoperfusion therapy in MIS-C patients, and the choice of charcoal hemoperfusion as an initial or rescue therapy is needed to be investigated in large patient groups both in children and adults who are diagnosed with COVID-19 and MIS-C.